Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials
10 pending office actions • 6 art units • 8 examiners • 0 of 10 (0%) have an AI response strategy ready • 8 patents granted in the last 365 days
Mexichem Fluor S A De C V manages 11 pending office actions within the Biotechnology & Pharmaceuticals technology area. These actions are spread across 6 distinct art units, reflecting a diverse range of chemical and biological subject matter in the company's patent applications. With 9 distinct examiners involved in these 11 cases, the company must navigate a variety of individual perspectives and examination styles.
SAEED, ALI S is the busiest examiner for this portfolio, currently overseeing 3 pending office actions. This examiner's involvement in 3 of the 11 total actions makes them a key figure in the company's current interactions with the USPTO. For practitioners, understanding the preferences of SAEED, ALI S is crucial, as their work represents a significant portion of the active Biotechnology & Pharmaceuticals filings for this company.
The distribution of 11 pending office actions across 6 distinct art units suggests that the company's research is multi-faceted. Because 9 distinct examiners are assigned to these cases, the company faces a broad spectrum of potential feedback. With SAEED, ALI S handling 3 actions, the remaining actions are distributed among other examiners, requiring a prosecution strategy that is both focused on key individuals and adaptable to many different examiners.
Based on the USPTO statutory response window for each pending office action. 6 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 6 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 2 (20%) |
| §112 only | 1 (10%) |
| Double-patenting only | 4 (40%) |
| Double-patenting + other | 1 (10%) |
| Multi-statute (no §101) | 2 (20%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| SAEED, ALI S | 3 | 31.3% | +35.8% |
| BASQUILL, SEAN M | 1 | 38.8% | +21.7% |
| CUTLIFF, YATE KAI RENE | 1 | 79.8% | +24.3% |
| DIAZ, MATTHEW R | 1 | 54.0% | +43.4% |
| BAHTA, MEDHANIT W | 1 | 80.6% | +28.2% |
| WEINER, LAURA S | 1 | 85.3% | +14.3% |
| GODENSCHWAGER, PETER F | 1 | 68.0% | +17.7% |
| DISNEY, CHRISTINE CONLON | 1 | 22.2% | +25.8% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18259324 | PROCESS FOR THE PRODUCTION OF 1,1-DIFLUOROETHANE | BAHTA, MEDHANIT W | 25d overdue |
| 18044835 | COMPOSITION | WEINER, LAURA S | 56d |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17767635 | COMPOSITION | DISNEY, CHRISTINE CONLON | 133d overdue |
| 18537034 | METHOD FOR PREPARING PARTIALLY FLUORINATED ALCOHOL | CUTLIFF, YATE KAI RENE | — |
| 17795417 | COMPOSITIONS | GODENSCHWAGER, PETER F | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17767635 | COMPOSITION | DISNEY, CHRISTINE CONLON | 133d overdue |
| 16334156 | PHARMACEUTICAL COMPOSITION | SAEED, ALI S | 35d overdue |
| 16582710 | PHARMACEUTICAL COMPOSITION | SAEED, ALI S | 30d overdue |
| 16582964 | PHARMACEUTICAL COMPOSITION | SAEED, ALI S | 30d overdue |
| 18259324 | PROCESS FOR THE PRODUCTION OF 1,1-DIFLUOROETHANE | BAHTA, MEDHANIT W | 25d overdue |
| 18044835 | COMPOSITION | WEINER, LAURA S | 56d |
| 19533595 | PHARMACEUTICAL COMPOSITION | BASQUILL, SEAN M | — |
| 18537034 | METHOD FOR PREPARING PARTIALLY FLUORINATED ALCOHOL | CUTLIFF, YATE KAI RENE | — |
| Art Unit | Apps |
|---|---|
| 1616 | 3 |
| 1692 | 2 |
| 1723 | 2 |
| 1614 | 1 |
| 1761 | 1 |
| 1767 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19533595 | PHARMACEUTICAL COMPOSITION | BASQUILL, SEAN M | 1614 | DP | Non-Final OA | — | Pending | Feb 09, 2026 |
| 18537034 | METHOD FOR PREPARING PARTIALLY FLUORINATED ALCOHOL | CUTLIFF, YATE KAI RENE | 1692 | §102§103 | Final Rejection | — | Pending | Dec 12, 2023 |
| 18473507 | COMPOSITIONS | DIAZ, MATTHEW R | 1761 | §103Other | Non-Final OA | — | Pending | Sep 25, 2023 |
| 18259324 | PROCESS FOR THE PRODUCTION OF 1,1-DIFLUOROETHANE | BAHTA, MEDHANIT W | 1692 | §103DP | Final Rejection | 25d overdue | Pending | Jun 26, 2023 |
| 18044835 | COMPOSITION | WEINER, LAURA S | 1723 | §112 | Final Rejection | 56d | Pending | Mar 10, 2023 |
| 17795417 | COMPOSITIONS | GODENSCHWAGER, PETER F | 1767 | §102§103§112 | Non-Final OA | — | Pending | Jul 26, 2022 |
| 17767635 | COMPOSITION | DISNEY, CHRISTINE CONLON | 1723 | §103 | Non-Final OA | 133d overdue | Pending | Apr 08, 2022 |
| 16582710 | PHARMACEUTICAL COMPOSITION | SAEED, ALI S | 1616 | DP | Non-Final OA | 30d overdue | Pending | Sep 25, 2019 |
| 16582964 | PHARMACEUTICAL COMPOSITION | SAEED, ALI S | 1616 | DP | Non-Final OA | 30d overdue | Pending | Sep 25, 2019 |
| 16334156 | PHARMACEUTICAL COMPOSITION | SAEED, ALI S | 1616 | DP | Non-Final OA | 35d overdue | Pending | Mar 18, 2019 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial